RCP
Remedium Capital Partners Portfolio holdings
AUM
$281M
This Fund
S&P 500
1 Year Est. Return
–
AUM
$281M
AUM Growth
+$111M
(+65%)
Holding
6
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ORKA
1
Oruka Therapeutics
ORKA
$3.5B
| $76.8M | 27.31% |
1,565,661
+13,247
|
|
||
2
Spyre Therapeutics
SYRE
$6.3B
| $73.5M | 26.13% |
1,456,231
|
|
||
|
DMRA
3
Damora Therapeutics
DMRA
$1.55B
| $53M | 18.84% |
2,045,473
+1,925,000
|
|
||
4
Apogee Therapeutics
APGE
$5.86B
| $49.1M | 17.47% |
583,591
|
|
||
|
JBIO
5
Jade Biosciences
JBIO
$1.06B
| $22.2M | 7.88% |
1,577,750
|
|
||
|
CBIO
6
Crescent Biopharma
CBIO
$573M
| $6.64M | 2.36% |
361,250
|
|